Technology
Upcoming Earnings
Health

MediciNova

$9.72
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.22 (2.32%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell MediciNova and other stocks, options, ETFs, and crypto commission-free!

About MNOV

Medicinova Inc Common Stock, also called MediciNova, is a biopharmaceutical company. It is engaged in acquiring and developing novel, small molecule therapeutics for the treatment of serious diseases for the treatment of diseases with unmet medical need. Read More The firm's development pipeline consists of clinical-stage compounds for the treatment of acute exacerbations of asthma and COPD, progressive multiple sclerosis, methamphetamine addiction, neuropathic pain, asthma, interstitial cystitis, and solid tumor cancers. The company was founded by Yuichi Iwaki on September 26, 2000 and is headquartered in La Jolla, CA.

Employees
9
Headquarters
La Jolla, California
Founded
2000
Market Cap
409.08M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
127.89K
High Today
$9.76
Low Today
$9.52
Open Price
$9.54
Volume
80.68K
52 Week High
$13.37
52 Week Low
$6.68

Collections

Technology
Upcoming Earnings
Health
Biotechnology
Medical
Biopharmaceutical
Therapy
Pharmaceutical

MNOV Earnings

-$0.16
-$0.11
-$0.06
-$0.01
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
-$0.12 per share
Actual
Expected Today, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.